Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Sampson

Showing results (261-270 of 393) with videos related to

Pageof 40
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2012
Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral gliomaBryan D Choi, Chien-Tsun Kuan, Mingqing Cai, et al.
Science Advances|July 20, 2022
Multiepitope supramolecular peptide nanofibers eliciting coordinated humoral and cellular antitumor immune responsesYaoying Wu, Hanning Wen, Zachary J Bernstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell functionPeter E Fecci, Hidenobu Ochiai, Duane A Mitchell, et al.
Cancer Research|March 17, 2006
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant gliomaPeter E Fecci, Duane A Mitchell, John F Whitesides, et al.
Cancer|April 30, 2009
Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant gliomaJennifer A Quinn, Sara Xiaoyin Jiang, David A Reardon, et al.
Anesthesia and Analgesia|February 24, 2022
Early Vasopressor Utilization Strategies and Outcomes in Critically Ill Patients With Severe Traumatic Brain InjuryCamilo Toro, Tetsu Ohnuma, Jordan Komisarow, et al.
International Journal of Cancer|May 2, 2009
IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide eraJoseph L Wiemels, David Wilson, Chirag Patil, et al.
Journal of Neurosurgery|June 14, 2014
Worse outcomes for patients undergoing brain tumor and cerebrovascular procedures following the ACGME resident duty-hour restrictionsRanjith Babu, Steven Thomas, Matthew A Hazzard, et al.
Journal of Neuro-Oncology|June 22, 2010
Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE studySabine Mueller, Mei-Yin Polley, Benjamin Lee, et al.
Journal of Neuro-Oncology|June 18, 2009
Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapyJennifer A Quinn, Sara Xiaoyin Jiang, David A Reardon, et al.
Pageof 40

Showing results (261-270 of 393) with videos related to

Sort By:
Pageof 40
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2012
Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral gliomaBryan D Choi, Chien-Tsun Kuan, Mingqing Cai, et al.
Science Advances|July 20, 2022
Multiepitope supramolecular peptide nanofibers eliciting coordinated humoral and cellular antitumor immune responsesYaoying Wu, Hanning Wen, Zachary J Bernstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell functionPeter E Fecci, Hidenobu Ochiai, Duane A Mitchell, et al.
Cancer Research|March 17, 2006
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant gliomaPeter E Fecci, Duane A Mitchell, John F Whitesides, et al.
Cancer|April 30, 2009
Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant gliomaJennifer A Quinn, Sara Xiaoyin Jiang, David A Reardon, et al.
Anesthesia and Analgesia|February 24, 2022
Early Vasopressor Utilization Strategies and Outcomes in Critically Ill Patients With Severe Traumatic Brain InjuryCamilo Toro, Tetsu Ohnuma, Jordan Komisarow, et al.
International Journal of Cancer|May 2, 2009
IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide eraJoseph L Wiemels, David Wilson, Chirag Patil, et al.
Journal of Neurosurgery|June 14, 2014
Worse outcomes for patients undergoing brain tumor and cerebrovascular procedures following the ACGME resident duty-hour restrictionsRanjith Babu, Steven Thomas, Matthew A Hazzard, et al.
Journal of Neuro-Oncology|June 22, 2010
Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE studySabine Mueller, Mei-Yin Polley, Benjamin Lee, et al.
Journal of Neuro-Oncology|June 18, 2009
Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapyJennifer A Quinn, Sara Xiaoyin Jiang, David A Reardon, et al.
Pageof 40